John Contois

VP, Laboratory Medicine at C2N Diagnostics

Dr. Contois received his PhD in nutritional sciences from the University of Connecticut where his doctoral research, in collaboration with the USDA Human Nutrition Research Center on Aging at Tufts University and the Framingham Heart Study, focused on the clinical utility of apolipoproteins as cardiovascular disease risk factors. Dr. Contois received his BS from the University of Massachusetts at Boston and MS from the University of Connecticut. He received postdoctoral training in Clinical Chemistry at Hartford Hospital and Epidemiology from the University of Texas M.D. Anderson Cancer Center. Dr. Contois received board certification in clinical chemistry (DABCC) and is a Fellow of the American Association of Clinical Chemistry (FAACC). He has served as Laboratory Director in both hospital and commercial laboratories, including Quest Diagnostics, the University of Massachusetts Medical Center, and LipoScience. Dr. Contois founded Sun Diagnostics as a “laboratory solutions provider” to provide products for labs and IVD manufacturers to simplify validation experiments and improve the quality of testing. He currently serves on the Editorial Boards of Clinica Chimica Acta, Practical Laboratory Medicine and the Journal of Clinical Lipidology. He has published more than 50 articles and book chapters.

Links

Previous companies

Timeline

  • VP, Laboratory Medicine

    March, 2022 - present